Counterpoint: Is there a need for supplemental XRT in intermediate-risk prostate cancer patients?

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Access to Document

@article{ddb7125030524b7699882902b74e3b55,

title = "Counterpoint: Is there a need for supplemental XRT in intermediate-risk prostate cancer patients?",

author = "Stone, {Nelson N.}",

year = "2013",

month = sep,

doi = "10.1016/j.brachy.2013.07.005",

language = "English",

volume = "12",

pages = "393--397",

journal = "Brachytherapy",

issn = "1538-4721",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Counterpoint

T2 - Is there a need for supplemental XRT in intermediate-risk prostate cancer patients?

AU - Stone, Nelson N.

PY - 2013/9

Y1 - 2013/9

UR - http://www.scopus.com/inward/record.url?scp=84883556666&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2013.07.005

DO - 10.1016/j.brachy.2013.07.005

M3 - Article

C2 - 23958340

AN - SCOPUS:84883556666

SN - 1538-4721

VL - 12

SP - 393

EP - 397

JO - Brachytherapy

JF - Brachytherapy

IS - 5

ER -